# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

A 510(k) Number K242428   
B Applicant Guangzhou Decheng Biotechnology Co., Ltd.   
C Proprietary and Established Names Fentanyl (FTY) Test System   
D Regulatory Information

<table><tr><td rowspan=1 colspan=1>ProductCode(s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>RegulationSection</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>NGL</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3650 -Opiate Test System</td><td rowspan=1 colspan=1>TX - ClinicalToxicology</td></tr></table>

II Submission/Device Overview:

A Purpose for Submission: New Device

# B Measurand:

# C Type of Test:

lateral flow immunochromatographic assay

# III Intended Use/Indications for Use:

A Intended Use(s): See Indications for Use below.

# B Indication(s) for Use:

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip is a competitive binding, lateral flow immunochromatographic assay for the qualitative detection of Fentanyl (FTY) in human urine at the cut-off concentration of $1 \mathrm { n g / m L }$ .

It is intended for over-the-counter (OTC) use. For in vitro diagnostic use only.

The test provides only preliminary results. To obtain a confirmed analytical result, a more specific alternative chemical method must be used. GC/MS or LC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when the preliminary result is positive.

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card is a competitive binding, lateral flow immunochromatographic assay for the qualitative detection of Fentanyl (FTY) in human urine at the cut-off concentration of $1 \mathrm { n g / m L }$ .

It is intended for over-the-counter (OTC) use. For in vitro diagnostic use only. The test provides only preliminary results. To obtain a confirmed analytical result, a more specific alternative chemical method must be used. GC/MS or LC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when the preliminary result is positive.

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup is a competitive binding, lateral flow immunochromatographic assay for the qualitative detection of Fentanyl (FTY) in human urine at the cut-off concentration of $1 \mathrm { n g / m L }$ .

It is intended for over-the-counter (OTC) use. For in vitro diagnostic use only. The test provides only preliminary results. To obtain a confirmed analytical result, a more specific alternative chemical method must be used. GC/MS or LC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when the preliminary result is positive.

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip Plus is a competitive binding, lateral flow immunochromatographic assay for the qualitative detection of Fentanyl (FTY) in human urine at the cut-off concentration of $1 \mathrm { n g / m L }$ .

For in vitro diagnostic use only.

The test provides only preliminary results. To obtain a confirmed analytical result, a more specific alternative chemical method must be used. GC/MS or LC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when the preliminary result is positive.

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card Plus is a competitive binding, lateral flow immunochromatographic assay for the qualitative detection of Fentanyl (FTY) in human urine at the cut-off concentration of $1 \mathrm { n g / m L }$ .

For in vitro diagnostic use only.

The test provides only preliminary results. To obtain a confirmed analytical result, a more specific alternative chemical method must be used. GC/MS or LC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when the preliminary result is positive.

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup Plus is a competitive binding, lateral flow immunochromatographic assay for the qualitative detection of Fentanyl (FTY) in human urine at the cut-off concentration of $1 \mathrm { n g / m L }$ .

For in vitro diagnostic use only.

The test provides only preliminary results. To obtain a confirmed analytical result, a more specific alternative chemical method must be used. GC/MS or LC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when the preliminary result is positive..

C Special Conditions for Use Statement(s):

OTC - Over The Counter

# D Special Instrument Requirements:

Not applicable

# IV Device/System Characteristics:

# A Device Description:

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip, Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip Plus, Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card, Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card Plus, Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup and Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup Plus are immunochromatographic assays that use a lateral flow system for the qualitative detection of fentanyl in human urine.

Test Strip, Test card and Test Cup use identical test strips made with same chemical formulation and manufacturing procedures.

# B Principle of Operation:

The Fentanyl (FTY) Test is an immunoassay based on the principle of competitive binding that is used to screen for the presence of Fentanyl in urine. It is a chromatographic absorbent device in which Fentanyl in a sample competitively combined to a limited number of antibody-dye conjugate binding sites.

During testing, the urine specimen migrates upward by capillary action. Fentanyl, if present in the urine specimen below $1 \mathrm { n g / m L }$ , will not saturate the binding sites of antibody-coated particles in the test device. The antibody-coated particles will then be captured by immobilized FTY conjugate and a visible colored line will appear in the test region (T) to indicate a negative result. The colored line will not appear in the test region (T) if the Fentanyl level exceeds 1 $\mathrm { n g / m L }$ because it will saturate all the binding sites of anti-FTY antibodies and prevent the development of a distinct colored line, which indicating a positive result.

To serve as a procedure control, a colored line will always appear at the control region (C), if the test has been performed properly.

# V Substantial Equivalence Information:

A Predicate Device Name(s): AllTest Fentanyl Rapid Test (Urine)

B Predicate 510(k) Number(s): K231698

C Comparison with Predicate(s):

<table><tr><td rowspan=1 colspan=1>Device &amp; PredicateDevice(s):</td><td rowspan=1 colspan=1>K242428</td><td rowspan=1 colspan=1>K231698</td></tr><tr><td rowspan=1 colspan=1>Device Trade Name</td><td rowspan=1 colspan=1>Dochek® FentanylUrine Test Strip,Dochek® FentanylUrine Test Strip Plus,Dochek® FentanylUrine Test Card,Dochek® FentanylUrine Test Card Plus,Dochek® FentanylUrine Test Cup andDochek® FentanylUrine Test Cup Plus</td><td rowspan=1 colspan=1>AllTest Fentanyl RapidTest (Urine)</td></tr><tr><td rowspan=1 colspan=1>General DeviceCharacteristic Similarities</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Indications For Use</td><td rowspan=1 colspan=1>For the qualitativedetermination offentanyl in humanurine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen</td><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>1 ng/mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding,lateral flowimmunochromatographic assay based on theprinciple of antigenantibodyimmunochemistry</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>2-30</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>General DeviceCharacteristic Differences</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Over-The-Counter Use</td><td rowspan=1 colspan=1>Prescription Use</td></tr><tr><td rowspan=1 colspan=1>Configuration</td><td rowspan=1 colspan=1>Strip, card, and cup</td><td rowspan=1 colspan=1>Cassette</td></tr></table>

# VI Standards/Guidance Documents Referenced:

Not applicable.

# VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

# 1. Precision/Reproducibility:

Precision study was performed using drug-free specimens spiked with Fentanyl at different concentrations: $0 \mathrm { n g / m L }$ , $0 . 2 5 \mathrm { n g / m L }$ , $0 . 5 \mathrm { n g / m L }$ , $0 . 7 5 \mathrm { n g / m L }$ , $1 \mathrm { n g / m L }$ , $1 . 2 5 \mathrm { n g / m L }$ , $1 . 5 \mathrm { n g / m L }$ , $1 . 7 5 \mathrm { n g / m L }$ , and $2 \mathrm { n g / m L }$ . All concentrations were confirmed with LC-MS/MS. The study was performed 3 runs per day and lasted for 10 non-consecutive days by 6 laboratory professionals using three different lots of Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip, Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card and Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup at the manufacturer site. 30 determinations were made for each concentration, and a total of 60 results were obtained per concentration per lot.

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip   

<table><tr><td rowspan=2 colspan=1>Sampleconcentration</td><td rowspan=2 colspan=1>% ofcutoff</td><td rowspan=1 colspan=2>Lot 1</td><td rowspan=1 colspan=2>Lot 2</td><td rowspan=1 colspan=2>Lot 3</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Ong/mL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>0.25ng/mL</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>0.5ng/mL</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>0.75ng/mL</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>56</td></tr><tr><td rowspan=1 colspan=1>1ng/mL</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>26</td></tr><tr><td rowspan=1 colspan=1>1.25ng/mL</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>1.5ng/mL</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>1.75ng/mL</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>2ng/mL</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td></tr></table>

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card   

<table><tr><td colspan="1" rowspan="2">Sampleconcentration</td><td colspan="1" rowspan="2">% ofcutoff</td><td colspan="2" rowspan="1">Lot 1</td><td colspan="2" rowspan="1">Lot 2</td><td colspan="2" rowspan="1">Lot 3</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Ong/mL</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">0.25ng/mL</td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">0.5ng/mL</td><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td></tr><tr><td colspan="1" rowspan="1">0.75ng/mL</td><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">54</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">58</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">56</td></tr><tr><td colspan="1" rowspan="1">1ng/mL</td><td colspan="1" rowspan="1">cutoff</td><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1">26</td></tr><tr><td colspan="1" rowspan="1">1.25ng/mL</td><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">58</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">58</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">54</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">1.5ng/mL</td><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">1.75ng/mL</td><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">2ng/mL</td><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">0</td></tr></table>

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup   

<table><tr><td rowspan=2 colspan=1>Sampleconcentration</td><td rowspan=2 colspan=1>% ofcutoff</td><td rowspan=1 colspan=2>Lot 1</td><td rowspan=1 colspan=2>Lot 2</td><td rowspan=1 colspan=2>Lot 3</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Ong/mL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>0.25ng/mL</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>0.5ng/mL</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>0.75ng/mL</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>58</td></tr><tr><td rowspan=1 colspan=1>1ng/mL</td><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>34</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>1.25ng/mL</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>58</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>56</td><td rowspan=1 colspan=1>4</td></tr><tr><td rowspan=1 colspan=1>1.5ng/mL</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>1.75ng/mL</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>2ng/mL</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>0</td></tr></table>

2. Linearity:

Not applicable. This device is intended for qualitative use only.

# 3. Analytical Specificity/Interference:

# a. Interference

Clinical urine samples may contain substances that could potentially interfere with the test. The following compounds were added to drug-free urine or drug positive urine containing Fentanyl with the concentration $50 \%$ below the cutoff and the concentration $50 \%$ above the cutoff, respectively. All potential interfering substances were added at a concentration of $1 0 0 \mu \mathrm { g / m L }$ or specified concentrations are summarized in the following tables. The urine specimens were tested with 3 lots of Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test. None of the substances listed below were shown to interfere.

Opioids compounds   

<table><tr><td colspan="1" rowspan="1">6-Acetyl morphine Amphetamine</td><td colspan="1" rowspan="1">6-Acetyl morphine Amphetamine</td><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">Buprenorphineglucuronide</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">EDDP</td></tr><tr><td colspan="1" rowspan="1">EMDP</td><td colspan="1" rowspan="1">Fluoxetine</td><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">Hydrocodone</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">Ketamine,</td><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">Meperidine</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">Morphine-3-glucuronide</td><td colspan="1" rowspan="1">Naloxone</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">Norbuprenorphine</td><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">Norketamine</td></tr><tr><td colspan="1" rowspan="1">Normeperidine</td><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">Noroxycodone</td><td colspan="1" rowspan="1">Oxycodone</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">Pentazocine(Talwin)</td><td colspan="1" rowspan="1">Pipamperone</td><td colspan="1" rowspan="1">Risperidone</td></tr><tr><td colspan="1" rowspan="1">Tapentadol</td><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">Tilidine</td><td colspan="1" rowspan="1">Tramadol</td></tr><tr><td colspan="1" rowspan="1">Tramadol-O-Desmethyl</td><td colspan="1" rowspan="1">Tramadol-N-Desmethyl</td><td colspan="1" rowspan="1">Trazodone</td><td colspan="1" rowspan="1"></td></tr></table>

Commonly ingested medications or substances   

<table><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>Doxepin (50 ug/mL)</td><td rowspan=1 colspan=1>Nortriptyline (25 ug/mL)</td></tr><tr><td rowspan=1 colspan=1>Acetone (1000 mg/dL)</td><td rowspan=1 colspan=1>Ecgonine methyl ester</td><td rowspan=1 colspan=1>Noscapine</td></tr><tr><td rowspan=1 colspan=1>Acetophenetidin</td><td rowspan=1 colspan=1>Ephedrine</td><td rowspan=1 colspan=1>O-Hydroxyhippuric acid</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic acid</td><td rowspan=1 colspan=1>Erythromycin</td><td rowspan=1 colspan=1>Octopamine</td></tr><tr><td rowspan=1 colspan=1>Albumin (100 mg/dL)</td><td rowspan=1 colspan=1>Ethanol (1%)</td><td rowspan=1 colspan=1>Oxalic acid (100 mg/dL)</td></tr><tr><td rowspan=1 colspan=1>Albuterol</td><td rowspan=1 colspan=1>Fenoprofen</td><td rowspan=1 colspan=1>Oxazepam</td></tr><tr><td rowspan=1 colspan=1>Aminopyrine</td><td rowspan=1 colspan=1>Fluphenazine</td><td rowspan=1 colspan=1>Oxolinic acid</td></tr><tr><td rowspan=1 colspan=1>Amitriptyline (35ug/mL</td><td rowspan=1 colspan=1>Furosemide</td><td rowspan=1 colspan=1>Oxymetazoline</td></tr><tr><td rowspan=1 colspan=1>Amobarbital</td><td rowspan=1 colspan=1>Galactose (10 mg/dL)</td><td rowspan=1 colspan=1>Papaverine</td></tr><tr><td rowspan=1 colspan=1>Amox1c1lln</td><td rowspan=1 colspan=1>Gamma Globulin(00mgdL)</td><td rowspan=1 colspan=1>Penicillin G</td></tr><tr><td rowspan=1 colspan=1>Ampicillin</td><td rowspan=1 colspan=1>Gentisic acid</td><td rowspan=1 colspan=1>Perphenazine</td></tr><tr><td rowspan=1 colspan=1>Apomorphine</td><td rowspan=1 colspan=1>Glucose (3000 mg/dL)</td><td rowspan=1 colspan=1>Phencyclidine</td></tr><tr><td rowspan=1 colspan=1>Ascorbic acid</td><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>Phenelzine</td></tr><tr><td rowspan=1 colspan=1>Aspartame</td><td rowspan=1 colspan=1>DL-Tyrosine</td><td rowspan=1 colspan=1>Prednisone</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>Hydralazine</td><td rowspan=1 colspan=1>Propoxyphene (50 ug/mL)</td></tr><tr><td rowspan=1 colspan=1>Benzilic acid</td><td rowspan=1 colspan=1>Hydrochlorothiazide</td><td rowspan=1 colspan=1>Propranolol</td></tr><tr><td rowspan=1 colspan=1>Benzoic acid</td><td rowspan=1 colspan=1>Hydrocortisone</td><td rowspan=1 colspan=1>Pseudoephedrine</td></tr><tr><td rowspan=1 colspan=1>Benzoylecgonine</td><td rowspan=1 colspan=1>Hydroxytyramine</td><td rowspan=1 colspan=1>Quinine</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>Ranitidine</td></tr><tr><td rowspan=1 colspan=1>Boric Acid (1%)</td><td rowspan=1 colspan=1>Imipramine(30 ug/mL)</td><td rowspan=1 colspan=1>Riboflavin (7.5 mg/dL)</td></tr><tr><td rowspan=1 colspan=1>Bupropion (50 ug/mL)</td><td rowspan=1 colspan=1>Isoproterenol</td><td rowspan=1 colspan=1>Salicylic acid</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>Isoxsuprine</td><td rowspan=1 colspan=1>Secobarbital</td></tr><tr><td rowspan=1 colspan=1>Carbamazepine</td><td rowspan=1 colspan=1>Ketoprofen</td><td rowspan=1 colspan=1>Serotonin (5-Hydroxytyramine)</td></tr><tr><td rowspan=1 colspan=1>Chloral hydrate</td><td rowspan=1 colspan=1>Labetalol</td><td rowspan=1 colspan=1>Sulfamethazine</td></tr><tr><td rowspan=1 colspan=1>Chloramphenicol</td><td rowspan=1 colspan=1>Lidocaine (50 ug/mL)</td><td rowspan=1 colspan=1>Sulindac</td></tr><tr><td rowspan=1 colspan=1>Chlorothiazide</td><td rowspan=1 colspan=1>Loperamide</td><td rowspan=1 colspan=1>Tetrahydrocortisone 3-(β-Dglucuronide)</td></tr><tr><td rowspan=1 colspan=1>Chlorpromazine</td><td rowspan=1 colspan=1>Maprotiline (50 ug/mL)</td><td rowspan=1 colspan=1>Tetrahydrocortisone 3-acetate</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>Meprobamate</td><td rowspan=1 colspan=1>Tetrahydrozoline</td></tr><tr><td rowspan=1 colspan=1>Clomipramine (50ug/mL)</td><td rowspan=1 colspan=1>Methapyrilene (10ug/mL</td><td rowspan=1 colspan=1>Thiamine</td></tr><tr><td rowspan=1 colspan=1>Clonidine</td><td rowspan=1 colspan=1>Methaqualone (50ug/mL)</td><td rowspan=1 colspan=1>Triamterene</td></tr><tr><td rowspan=1 colspan=1>Cortisone</td><td rowspan=1 colspan=1>Methoxyphenamine</td><td rowspan=1 colspan=1>Trifluoperazine</td></tr><tr><td rowspan=1 colspan=1>Cotinine</td><td rowspan=1 colspan=1>Metronidazole (300ug/mL)</td><td rowspan=1 colspan=1>Trimethoprim</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>N-AcetyIprocainamide</td><td rowspan=1 colspan=1>Tyramine</td></tr><tr><td rowspan=1 colspan=1>Cyclobenzaprine (10ug/mL)</td><td rowspan=1 colspan=1>NaCl (4000 mg/dL)</td><td rowspan=1 colspan=1>Urea (2000 mg/dL)</td></tr><tr><td rowspan=1 colspan=1>Deoxycorticosterone</td><td rowspan=1 colspan=1>Nalidixic acid</td><td rowspan=1 colspan=1>Uric acid</td></tr><tr><td rowspan=1 colspan=1>Desipramine (50ug/mL)</td><td rowspan=1 colspan=1>Naproxen</td><td rowspan=1 colspan=1>Valproic acid (250 ug/mL)</td></tr><tr><td rowspan=1 colspan=1>Diclofenac</td><td rowspan=1 colspan=1>Niacinamide</td><td rowspan=1 colspan=1>Venlafaxine</td></tr><tr><td rowspan=1 colspan=1>Diflunisal</td><td rowspan=1 colspan=1>Nicotine (10 ug/mL)</td><td rowspan=1 colspan=1>Verapamil</td></tr><tr><td rowspan=1 colspan=1>Digoxin</td><td rowspan=1 colspan=1>Nifedipine</td><td rowspan=1 colspan=1>Zomepirac</td></tr><tr><td rowspan=1 colspan=1>Diphenhydramine</td><td rowspan=1 colspan=1>Norethindrone</td><td rowspan=1 colspan=1>β-Estradiol</td></tr><tr><td rowspan=1 colspan=1>DL-Tryptophan</td><td rowspan=1 colspan=1>Phenobarbital</td><td rowspan=1 colspan=1></td></tr></table>

# Cross-Reactivity

The following table lists the lowest concentration $\mathrm { ( n g / m L ) }$ of compounds that gave a positive result on the Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test at the tested concentrations shown.

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>LowestConcentration(ng/mL)</td><td rowspan=1 colspan=1>% Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Acetyl fentanyl</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Acetyl norfentanyl</td><td rowspan=1 colspan=1>10,000</td><td rowspan=1 colspan=1>0.01</td></tr><tr><td rowspan=1 colspan=1>Acrylfentanyl</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>66.7</td></tr><tr><td rowspan=1 colspan=1>Butyryl fentanyl</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>Carfentanil</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>(±)-3-cis-methylfentanyl</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1>4-Fluoro-isobutyrylfentanyl</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Furanyl fentanyl</td><td rowspan=1 colspan=1>2.8</td><td rowspan=1 colspan=1>35.7</td></tr><tr><td rowspan=1 colspan=1>ω-1-Hydroxyfentanyl</td><td rowspan=1 colspan=1>20,000</td><td rowspan=1 colspan=1>0.005</td></tr><tr><td rowspan=1 colspan=1>(±) β-hydroxythiofentanyl</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>66.7</td></tr><tr><td rowspan=1 colspan=1>Isobutyryl fentanyl</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Ocfentanil</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>55.6</td></tr><tr><td rowspan=1 colspan=1>Para-fluorobutyrylfentanyl (p-FBF)</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Para-fluoro fentanyl</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>33.3</td></tr><tr><td rowspan=1 colspan=1>Sufentanil</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>5</td></tr><tr><td rowspan=1 colspan=1>Valeryl fentanyl</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Alfentanil</td><td rowspan=1 colspan=1>5,000</td><td rowspan=1 colspan=1>0.02</td></tr><tr><td rowspan=1 colspan=1>Despropionyl fentanyl (4-ANPP)</td><td rowspan=1 colspan=1>20,000</td><td rowspan=1 colspan=1>0.005</td></tr><tr><td rowspan=1 colspan=1>Remifentanil</td><td rowspan=1 colspan=1>10,000</td><td rowspan=1 colspan=1>0.01</td></tr><tr><td rowspan=1 colspan=1>Norcarfentanil</td><td rowspan=1 colspan=1>10,000</td><td rowspan=1 colspan=1>0.01</td></tr><tr><td rowspan=1 colspan=1>Norfentanyl</td><td rowspan=1 colspan=1>10,000</td><td rowspan=1 colspan=1>0.01</td></tr></table>

# Effect of Urine Specific Gravity and Urine pH

To investigate the effect of urine specific gravity and urine $\mathsf { p H }$ , urine samples, with 1.000, 1.005, 1.010, 1.0154, 1.02, 1.025, 1.030, and 1.035 specific gravity or urine samples with $\mathsf { p H }$ 4, 5, 6, 7, 8, and 9 were spiked with Fentanyl targets at $50 \%$ below and $50 \%$ above Cut-Off levels. These samples were tested using three lots of device. Results were all positive for samples at and above $+ 5 0 \%$ Cut- Offs and all negative for samples at and below $- 5 0 \%$ CutOffs.

4. Assay Reportable Range: Not applicable.

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods):

6. Detection Limit: Not applicable.

7. Assay Cut-Off: Not applicable.

# B Comparison Studies:

1. Method Comparison with Predicate Device:

80 clinical urine specimens were analyzed by LC/MS and by 3 lots of the corresponding Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip, Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card and Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup. Samples were divided by concentration into five categories: drug free, less than half the cutoff, near cutoff negative, near cutoff positive, and high positive. The study was conducted by 3 laboratory professionals at the manufacturer site. Results were as follows.

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(Less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Betweencutoff and+50%)</td><td rowspan=1 colspan=1>HighPositive byLC/MS(Greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer 1</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer 2</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer 3</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

# Analysis of Discordant Results (Strip)

<table><tr><td colspan="1" rowspan="1">Operator</td><td colspan="1" rowspan="1">Sample ID</td><td colspan="1" rowspan="1">Test Result</td><td colspan="1" rowspan="1">LC/MS Result(ng/mL)</td></tr><tr><td colspan="1" rowspan="2">Viewer 1</td><td colspan="1" rowspan="1">F046-6</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0.945</td></tr><tr><td colspan="1" rowspan="1">F062-5</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">1.012</td></tr><tr><td colspan="1" rowspan="2">Viewer 2</td><td colspan="1" rowspan="1">F045-3</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0.894</td></tr><tr><td colspan="1" rowspan="1">F062-6</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">1.012</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">F060-3</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0.920</td></tr><tr><td>Viewer 3</td><td>F088-1</td><td>Negative</td><td>1.077</td></tr></table>

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(Less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Betweencutoff and+50%</td><td rowspan=1 colspan=1>HighPositive byLC/MS(Greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer 1</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer 2</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer 3</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

# Analysis of Discordant Results (Card)

<table><tr><td rowspan=1 colspan=1>Operator</td><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>Test Result</td><td rowspan=1 colspan=1>LC/MS Result(ng/mL)</td></tr><tr><td rowspan=2 colspan=1>Viewer 1</td><td rowspan=1 colspan=1>F043-6</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0.885</td></tr><tr><td rowspan=1 colspan=1>F062-2</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1.012</td></tr><tr><td rowspan=2 colspan=1>Viewer 2</td><td rowspan=1 colspan=1>F055-6</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0.894</td></tr><tr><td rowspan=1 colspan=1>F083-4</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1.020</td></tr><tr><td rowspan=2 colspan=1>Viewer 3</td><td rowspan=1 colspan=1>F046-2</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0.945</td></tr><tr><td rowspan=1 colspan=1>F062-1</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1.012</td></tr></table>

Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(Less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Betweencutoff and+50%</td><td rowspan=1 colspan=1>HighPositive byLC/MS(Greaterthan +50%)</td></tr><tr><td rowspan=2 colspan=1>Viewer 1</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer 2</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer 3</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>13</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

# Analysis of Discordant Results (Cup)

<table><tr><td>Operator</td><td>Sample ID</td><td>Test Result</td><td>LC/MS Result (ng/mL)</td></tr><tr><td colspan="1" rowspan="2">Viewer 1</td><td colspan="1" rowspan="1">F055-8</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0.894</td></tr><tr><td colspan="1" rowspan="1">F049-8</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">1.044</td></tr><tr><td colspan="1" rowspan="2">Viewer 2</td><td colspan="1" rowspan="1">F046-4</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0.945</td></tr><tr><td colspan="1" rowspan="1">F049-9</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">1.044</td></tr><tr><td colspan="1" rowspan="2">Viewer 3</td><td colspan="1" rowspan="1">F060-9</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0.920</td></tr><tr><td colspan="1" rowspan="1">F062-4</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">1.012</td></tr></table>

2. Matrix Comparison: Not applicable.

# C Clinical Studies:

1. Clinical Sensitivity: Not applicable.

2. Clinical Specificity: Not applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable):

# Lay User Study

A lay user study was performed at three intended user sites with 980 lay persons. They had diverse educational and professional backgrounds and ranged in age from 20 to 65 years. Urine samples were prepared at the following concentrations: $0 \mathrm { n g / m L }$ , $0 . 2 5 ~ \mathrm { n g / m L }$ $0 . 5 \mathrm { n g / m L }$ , $0 . 7 5 \mathrm { n g / m L }$ , $1 . 2 5 \mathrm { n g / m L }$ , $1 . 5 \mathrm { n g / m L }$ , $1 . 7 5 \mathrm { n g / m L }$ cutoff by spiking target drug fentanyl into drug free urine specimens. The concentrations of samples were confirmed by LC/MS. Each sample was aliquoted into individual containers, blind-labeled and randomized. Each participant was provided with the English package insert, 1 blind labeled sample, and a device. Results were as follows:

Lay user study date of Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Strip:   

<table><tr><td colspan="1" rowspan="2">Sampleconcentration</td><td colspan="1" rowspan="2">% ofcutoff</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="2" rowspan="1">Layer userResults</td><td colspan="1" rowspan="2">Agreement(%)</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Ong/mL</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">0.25ng/mL</td><td colspan="1" rowspan="1">-75%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">0.5ng/mL</td><td colspan="1" rowspan="1">-50%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">0.75ng/mL</td><td colspan="1" rowspan="1">-25%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">38</td><td colspan="1" rowspan="1">95%</td></tr><tr><td colspan="1" rowspan="1">1.25ng/mL</td><td colspan="1" rowspan="1">+25%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">38</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">95%</td></tr><tr><td colspan="1" rowspan="1">1.5ng/mL</td><td colspan="1" rowspan="1">+50%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">1.75ng/mL</td><td colspan="1" rowspan="1">+75%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr></table>

Lay user study date of Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card (Cassette method):   

<table><tr><td rowspan=2 colspan=1>Sampleconcentration</td><td rowspan=2 colspan=1>% ofcutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=1 colspan=2>Layer userResults</td><td rowspan=2 colspan=1>Agreement(%)</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Ong/mL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>0.25ng/mL</td><td rowspan=1 colspan=1>-75%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>0.5ng/mL</td><td rowspan=1 colspan=1>-50%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>0.75ng/mL</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>96.7%</td></tr><tr><td rowspan=1 colspan=1>1.25ng/mL</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>93.3%</td></tr><tr><td rowspan=1 colspan=1>1.5ng/mL</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>1.75ng/mL</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Lay user study date of Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Card (Dip card method):   

<table><tr><td rowspan=2 colspan=1>Sampleconcentration</td><td rowspan=2 colspan=1>% ofcutoff</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=1 colspan=2>Layer userResults</td><td rowspan=2 colspan=1>Agreement(%)</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>0ng/mL</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>0.25ng/mL</td><td rowspan=1 colspan=1>-75%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>0.5ng/mL</td><td rowspan=1 colspan=1>-50%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>0.75ng/mL</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>93.3%</td></tr><tr><td rowspan=1 colspan=1>1.25ng/mL</td><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>96.7%</td></tr><tr><td rowspan=1 colspan=1>1.5ng/mL</td><td rowspan=1 colspan=1>+50%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>1.75ng/mL</td><td rowspan=1 colspan=1>+75%cutoff</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr></table>

Lay user study date of Dochek $\textsuperscript { \textregistered }$ Fentanyl Urine Test Cup:   

<table><tr><td colspan="1" rowspan="2">Sampleconcentration</td><td colspan="1" rowspan="2">% ofcutoff</td><td colspan="1" rowspan="2">Number ofsamples</td><td colspan="2" rowspan="1">Layer userResults</td><td colspan="1" rowspan="2">Agreement(%)</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">Negative</td></tr><tr><td colspan="1" rowspan="1">Ong/mL</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">0.25ng/mL</td><td colspan="1" rowspan="1">-75%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">0.5ng/mL</td><td colspan="1" rowspan="1">-50%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">0.75ng/mL</td><td colspan="1" rowspan="1">-25%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">92.5%</td></tr><tr><td colspan="1" rowspan="1">1.25ng/mL</td><td colspan="1" rowspan="1">+25%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">92.5%</td></tr><tr><td colspan="1" rowspan="1">1.5ng/mL</td><td colspan="1" rowspan="1">+50%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">1.75ng/mL</td><td colspan="1" rowspan="1">+75%cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100%</td></tr></table>

# D Clinical Cut-Off:

Not applicable

# E Expected Values/Reference Range

Not applicable

# VIII Proposed Labeling:

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.